IBDEI0TK.m

IBDEI0TK ; ; 01-FEB-2022

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,13301,1,4,0)

 ;;=4^H35.3122

 ;;^UTILITY(U,$J,358.3,13301,2)

 ;;=^5138507

 ;;^UTILITY(U,$J,358.3,13302,0)

 ;;=H35.3123^^51^633^10

 ;;^UTILITY(U,$J,358.3,13302,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13302,1,3,0)

 ;;=3^NonEx AMD,OS,Adv Atrpc w/o Sbfvl Invlv

 ;;^UTILITY(U,$J,358.3,13302,1,4,0)

 ;;=4^H35.3123

 ;;^UTILITY(U,$J,358.3,13302,2)

 ;;=^5138508

 ;;^UTILITY(U,$J,358.3,13303,0)

 ;;=H35.3124^^51^633^11

 ;;^UTILITY(U,$J,358.3,13303,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13303,1,3,0)

 ;;=3^NonEx AMD,OS,Adv Atrpc w/ Sbfvl Invlv

 ;;^UTILITY(U,$J,358.3,13303,1,4,0)

 ;;=4^H35.3124

 ;;^UTILITY(U,$J,358.3,13303,2)

 ;;=^5138509

 ;;^UTILITY(U,$J,358.3,13304,0)

 ;;=H35.3110^^51^633^2

 ;;^UTILITY(U,$J,358.3,13304,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13304,1,3,0)

 ;;=3^NonEx AMD,OD,Stage Unspec

 ;;^UTILITY(U,$J,358.3,13304,1,4,0)

 ;;=4^H35.3110

 ;;^UTILITY(U,$J,358.3,13304,2)

 ;;=^5138500

 ;;^UTILITY(U,$J,358.3,13305,0)

 ;;=H35.3111^^51^633^3

 ;;^UTILITY(U,$J,358.3,13305,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13305,1,3,0)

 ;;=3^NonEx AMD,OD,Early Dry Stage

 ;;^UTILITY(U,$J,358.3,13305,1,4,0)

 ;;=4^H35.3111

 ;;^UTILITY(U,$J,358.3,13305,2)

 ;;=^5138501

 ;;^UTILITY(U,$J,358.3,13306,0)

 ;;=H35.3112^^51^633^4

 ;;^UTILITY(U,$J,358.3,13306,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13306,1,3,0)

 ;;=3^NonEx AMD,OD,Intermed Dry Stage

 ;;^UTILITY(U,$J,358.3,13306,1,4,0)

 ;;=4^H35.3112

 ;;^UTILITY(U,$J,358.3,13306,2)

 ;;=^5138502

 ;;^UTILITY(U,$J,358.3,13307,0)

 ;;=H35.3113^^51^633^5

 ;;^UTILITY(U,$J,358.3,13307,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13307,1,3,0)

 ;;=3^NonEx AMD,OD,Adv Atrpc w/o Sbfvl Invlv

 ;;^UTILITY(U,$J,358.3,13307,1,4,0)

 ;;=4^H35.3113

 ;;^UTILITY(U,$J,358.3,13307,2)

 ;;=^5138503

 ;;^UTILITY(U,$J,358.3,13308,0)

 ;;=H35.3114^^51^633^6

 ;;^UTILITY(U,$J,358.3,13308,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13308,1,3,0)

 ;;=3^NonEx AMD,OD,Adv Atrpc w/ Subfvl Invlv

 ;;^UTILITY(U,$J,358.3,13308,1,4,0)

 ;;=4^H35.3114

 ;;^UTILITY(U,$J,358.3,13308,2)

 ;;=^5138504

 ;;^UTILITY(U,$J,358.3,13309,0)

 ;;=H32.^^51^634^12

 ;;^UTILITY(U,$J,358.3,13309,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13309,1,3,0)

 ;;=3^Chorioretinal Disorders,Secondary,Unspec

 ;;^UTILITY(U,$J,358.3,13309,1,4,0)

 ;;=4^H32.

 ;;^UTILITY(U,$J,358.3,13309,2)

 ;;=^5005489

 ;;^UTILITY(U,$J,358.3,13310,0)

 ;;=H30.93^^51^634^11

 ;;^UTILITY(U,$J,358.3,13310,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13310,1,3,0)

 ;;=3^Chorioretinal Inflammation,Unspec,OU

 ;;^UTILITY(U,$J,358.3,13310,1,4,0)

 ;;=4^H30.93

 ;;^UTILITY(U,$J,358.3,13310,2)

 ;;=^5005435

 ;;^UTILITY(U,$J,358.3,13311,0)

 ;;=H30.91^^51^634^9

 ;;^UTILITY(U,$J,358.3,13311,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13311,1,3,0)

 ;;=3^Chorioretinal Inflammation,Unspec,OD

 ;;^UTILITY(U,$J,358.3,13311,1,4,0)

 ;;=4^H30.91

 ;;^UTILITY(U,$J,358.3,13311,2)

 ;;=^5133481

 ;;^UTILITY(U,$J,358.3,13312,0)

 ;;=H30.92^^51^634^10

 ;;^UTILITY(U,$J,358.3,13312,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13312,1,3,0)

 ;;=3^Chorioretinal Inflammation,Unspec,OS

 ;;^UTILITY(U,$J,358.3,13312,1,4,0)

 ;;=4^H30.92

 ;;^UTILITY(U,$J,358.3,13312,2)

 ;;=^5133482

 ;;^UTILITY(U,$J,358.3,13313,0)

 ;;=H31.003^^51^634^15

 ;;^UTILITY(U,$J,358.3,13313,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,13313,1,3,0)

 ;;=3^Chorioretinal Scars,Unspec,OU

 ;;^UTILITY(U,$J,358.3,13313,1,4,0)

 ;;=4^H31.003

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---IBDEI0TK   3777     printed  Mar 13, 2025@21:00:09                                                                                                                                                                                                    Page 2

IBDEI0TK  ; ; 01-FEB-2022

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022

 +2        if 'DIFQR(358.3)

               QUIT 

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT 

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT 

 +1       ;;^UTILITY(U,$J,358.3,13301,1,4,0)

 +2       ;;=4^H35.3122

 +3       ;;^UTILITY(U,$J,358.3,13301,2)

 +4       ;;=^5138507

 +5       ;;^UTILITY(U,$J,358.3,13302,0)

 +6       ;;=H35.3123^^51^633^10

 +7       ;;^UTILITY(U,$J,358.3,13302,1,0)

 +8       ;;=^358.31IA^4^2

 +9       ;;^UTILITY(U,$J,358.3,13302,1,3,0)

 +10      ;;=3^NonEx AMD,OS,Adv Atrpc w/o Sbfvl Invlv

 +11      ;;^UTILITY(U,$J,358.3,13302,1,4,0)

 +12      ;;=4^H35.3123

 +13      ;;^UTILITY(U,$J,358.3,13302,2)

 +14      ;;=^5138508

 +15      ;;^UTILITY(U,$J,358.3,13303,0)

 +16      ;;=H35.3124^^51^633^11

 +17      ;;^UTILITY(U,$J,358.3,13303,1,0)

 +18      ;;=^358.31IA^4^2

 +19      ;;^UTILITY(U,$J,358.3,13303,1,3,0)

 +20      ;;=3^NonEx AMD,OS,Adv Atrpc w/ Sbfvl Invlv

 +21      ;;^UTILITY(U,$J,358.3,13303,1,4,0)

 +22      ;;=4^H35.3124

 +23      ;;^UTILITY(U,$J,358.3,13303,2)

 +24      ;;=^5138509

 +25      ;;^UTILITY(U,$J,358.3,13304,0)

 +26      ;;=H35.3110^^51^633^2

 +27      ;;^UTILITY(U,$J,358.3,13304,1,0)

 +28      ;;=^358.31IA^4^2

 +29      ;;^UTILITY(U,$J,358.3,13304,1,3,0)

 +30      ;;=3^NonEx AMD,OD,Stage Unspec

 +31      ;;^UTILITY(U,$J,358.3,13304,1,4,0)

 +32      ;;=4^H35.3110

 +33      ;;^UTILITY(U,$J,358.3,13304,2)

 +34      ;;=^5138500

 +35      ;;^UTILITY(U,$J,358.3,13305,0)

 +36      ;;=H35.3111^^51^633^3

 +37      ;;^UTILITY(U,$J,358.3,13305,1,0)

 +38      ;;=^358.31IA^4^2

 +39      ;;^UTILITY(U,$J,358.3,13305,1,3,0)

 +40      ;;=3^NonEx AMD,OD,Early Dry Stage

 +41      ;;^UTILITY(U,$J,358.3,13305,1,4,0)

 +42      ;;=4^H35.3111

 +43      ;;^UTILITY(U,$J,358.3,13305,2)

 +44      ;;=^5138501

 +45      ;;^UTILITY(U,$J,358.3,13306,0)

 +46      ;;=H35.3112^^51^633^4

 +47      ;;^UTILITY(U,$J,358.3,13306,1,0)

 +48      ;;=^358.31IA^4^2

 +49      ;;^UTILITY(U,$J,358.3,13306,1,3,0)

 +50      ;;=3^NonEx AMD,OD,Intermed Dry Stage

 +51      ;;^UTILITY(U,$J,358.3,13306,1,4,0)

 +52      ;;=4^H35.3112

 +53      ;;^UTILITY(U,$J,358.3,13306,2)

 +54      ;;=^5138502

 +55      ;;^UTILITY(U,$J,358.3,13307,0)

 +56      ;;=H35.3113^^51^633^5

 +57      ;;^UTILITY(U,$J,358.3,13307,1,0)

 +58      ;;=^358.31IA^4^2

 +59      ;;^UTILITY(U,$J,358.3,13307,1,3,0)

 +60      ;;=3^NonEx AMD,OD,Adv Atrpc w/o Sbfvl Invlv

 +61      ;;^UTILITY(U,$J,358.3,13307,1,4,0)

 +62      ;;=4^H35.3113

 +63      ;;^UTILITY(U,$J,358.3,13307,2)

 +64      ;;=^5138503

 +65      ;;^UTILITY(U,$J,358.3,13308,0)

 +66      ;;=H35.3114^^51^633^6

 +67      ;;^UTILITY(U,$J,358.3,13308,1,0)

 +68      ;;=^358.31IA^4^2

 +69      ;;^UTILITY(U,$J,358.3,13308,1,3,0)

 +70      ;;=3^NonEx AMD,OD,Adv Atrpc w/ Subfvl Invlv

 +71      ;;^UTILITY(U,$J,358.3,13308,1,4,0)

 +72      ;;=4^H35.3114

 +73      ;;^UTILITY(U,$J,358.3,13308,2)

 +74      ;;=^5138504

 +75      ;;^UTILITY(U,$J,358.3,13309,0)

 +76      ;;=H32.^^51^634^12

 +77      ;;^UTILITY(U,$J,358.3,13309,1,0)

 +78      ;;=^358.31IA^4^2

 +79      ;;^UTILITY(U,$J,358.3,13309,1,3,0)

 +80      ;;=3^Chorioretinal Disorders,Secondary,Unspec

 +81      ;;^UTILITY(U,$J,358.3,13309,1,4,0)

 +82      ;;=4^H32.

 +83      ;;^UTILITY(U,$J,358.3,13309,2)

 +84      ;;=^5005489

 +85      ;;^UTILITY(U,$J,358.3,13310,0)

 +86      ;;=H30.93^^51^634^11

 +87      ;;^UTILITY(U,$J,358.3,13310,1,0)

 +88      ;;=^358.31IA^4^2

 +89      ;;^UTILITY(U,$J,358.3,13310,1,3,0)

 +90      ;;=3^Chorioretinal Inflammation,Unspec,OU

 +91      ;;^UTILITY(U,$J,358.3,13310,1,4,0)

 +92      ;;=4^H30.93

 +93      ;;^UTILITY(U,$J,358.3,13310,2)

 +94      ;;=^5005435

 +95      ;;^UTILITY(U,$J,358.3,13311,0)

 +96      ;;=H30.91^^51^634^9

 +97      ;;^UTILITY(U,$J,358.3,13311,1,0)

 +98      ;;=^358.31IA^4^2

 +99      ;;^UTILITY(U,$J,358.3,13311,1,3,0)

 +100     ;;=3^Chorioretinal Inflammation,Unspec,OD

 +101     ;;^UTILITY(U,$J,358.3,13311,1,4,0)

 +102     ;;=4^H30.91

 +103     ;;^UTILITY(U,$J,358.3,13311,2)

 +104     ;;=^5133481

 +105     ;;^UTILITY(U,$J,358.3,13312,0)

 +106     ;;=H30.92^^51^634^10

 +107     ;;^UTILITY(U,$J,358.3,13312,1,0)

 +108     ;;=^358.31IA^4^2

 +109     ;;^UTILITY(U,$J,358.3,13312,1,3,0)

 +110     ;;=3^Chorioretinal Inflammation,Unspec,OS

 +111     ;;^UTILITY(U,$J,358.3,13312,1,4,0)

 +112     ;;=4^H30.92

 +113     ;;^UTILITY(U,$J,358.3,13312,2)

 +114     ;;=^5133482

 +115     ;;^UTILITY(U,$J,358.3,13313,0)

 +116     ;;=H31.003^^51^634^15

 +117     ;;^UTILITY(U,$J,358.3,13313,1,0)

 +118     ;;=^358.31IA^4^2

 +119     ;;^UTILITY(U,$J,358.3,13313,1,3,0)

 +120     ;;=3^Chorioretinal Scars,Unspec,OU

 +121     ;;^UTILITY(U,$J,358.3,13313,1,4,0)

 +122     ;;=4^H31.003